Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. [electronic resource]
Producer: 20070220Description: 437-41 p. digitalISSN:- 1476-4687
- Breast Neoplasms -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Feedback, Physiological
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-akt -- metabolism
- Receptor, ErbB-2 -- antagonists & inhibitors
- Receptor, ErbB-3 -- metabolism
- Signal Transduction
- Substrate Specificity
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.